Inventor · disambiguated record
Ilya Serebriiskii
Also filed as: SEREBRIISKII ILYA · SEREBRIISKII ILYA G
7 granted patents·4 pending applications·45 citations·filing 1998–2020
80Inventor score
Files withFOX CHASE CANCER CT3INSTITUTE FOR CANCER RES2ASTSATUROV IGOR1FOX CHASE CANCER CENTER1INSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER1
Top patents by PatentIndex Score
11 records- 0193US7919610B2Yeast bacterial two-hybrid system and methods of use thereofFOX CHASE CANCER CT·Filed 2005·Granted Apr 5, 2011·27 cites·7 claims
- 0277US10328050B2C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibitionINSTITUTE FOR CANCER RES·Filed 2018·Granted Jun 25, 2019·1 cites·14 claims
- 0376US10724100B2Systems and methods for treating patients having a genetic predisposition to develop prostate cancerINSTITUTE FOR CANCER RES·Filed 2015·Granted Jul 28, 2020·2 cites·22 claims
- 0458US9101631B2Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancerRATUSHNY VLADIMIR·Filed 2009·Granted Aug 11, 2015·0 cites·13 claims
- 0557US10450613B2EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersFOX CHASE CANCER CENTER·Filed 2016·Granted Oct 22, 2019·0 cites·2 claims
- 0654US2021010087A1Systems And Methods For Treating Patients Having A Genetic Predisposition To Develop Prostate CancerINSTITUTE FOR CANCER RES D/B/A THE RES INSTITUTE OF FOX CHASE CANCER CENTER·Filed 2020·Application pending·0 cites
- 0753US2013331294A1Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersFOX CHASE CANCER CT·Filed 2013·Application pending·0 cites
- 0852US6326150B1Yeast interaction trap assayFOX CHASE CANCER CT·Filed 1998·Granted Dec 4, 2001·15 cites·21 claims
- 0945US2003211495A1Reverse n-hybrid screening methodFiled 2001·Application pending·0 cites
- 1042US9677072B2Methods of inhibiting proliferation of estrogen-independent cancer cellsWEINER LOUIS M·Filed 2012·Granted Jun 13, 2017·0 cites·3 claims
- 1138US2010239656A1Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disordersASTSATUROV IGOR·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ilya Serebriiskii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →